Physician profile
Joseph A Graham
NPI 1225096860
$4,990.13
in general payments reported to CMS, 2019-2025
33 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,250 · 2020: $294 · 2021: $924 · 2022: $522 · 2023: $330 · 2024: $326 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,673.23 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Abiomed | $1,028.92 | 2019 | |
| Janssen Pharmaceuticals, INC | $493.03 | 2019-2024 | Xarelto |
| Endologix LLC | $294.20 | 2020-2025 | Endocross Device, Torus Stent Graft System |
| Abbott Laboratories | $217.22 | 2021-2025 | Supera, Esprit, Xact |
| W. L. Gore & Associates, INC. | $174.34 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Cvrx, INC. | $129.53 | 2024-2025 | Barostim Neo System |
| Cardiovascular Systems INC. | $84.63 | 2022-2023 | Diamondback Peripheral |
| Cook Medical LLC | $80.82 | 2020-2022 | |
| Imperative Care, INC | $78.49 | 2024 | Symphony Catheter, Prodigy Catheter |
| Medtronic, INC. | $69.32 | 2021-2022 | |
| Boston Scientific Corporation | $65.90 | 2021-2025 | General - Thrombectomy |
| Philips North America LLC | $59.95 | 2020-2022 | |
| Angiodynamics, INC. | $57.61 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Veryan Medical Incorporated | $48.41 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $37.72 | 2025 | |
| 4web, INC. | $36.00 | 2022 | |
| Penumbra, INC. | $33.33 | 2023 | Smart Coil |
| Lemaitre Vascular, INC. | $33.01 | 2019-2024 | Artegraft Vascular Graft |
| Lifenet Health | $29.71 | 2024 | Theragenesis Wound Matrix |
| Cardiva Medical, INC. | $25.95 | 2019 | |
| Baxter Healthcare | $24.66 | 2021 | |
| Venturemed Group, INC. | $22.91 | 2021 | |
| Getinge USA Sales, LLC | $22.63 | 2021 | |
| Urgo Medical North America, LLC | $22.42 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Ekos Corporation | $21.67 | 2019 | |
| Mallinckrodt Enterprises LLC | $21.28 | 2019 | |
| Surmodics, INC. | $20.76 | 2023 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Bard Peripheral Vascular, INC. | $19.88 | 2020 | |
| Csl Behring | $19.82 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.77 | 2023 | |
| Pfizer INC. | $13.14 | 2021 | |
| Smith+Nephew, INC. | $12.87 | 2023 | Renasys Go V2 Home, Renasys Touch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.